Deallus is formerly owned by ARCHIMED, through MED I, since 2015.

When did ARCHIMED acquire Deallus?

ARCHIMED acquired Deallus in 2015 and exited after 9 years.

Has Deallus been sold?

Yes. Deallus was exited in 2024 via Secondary.

Home/Companies/Pharma/Deallus

Deallus

Pharma·

UK·Exited 2024·Held 9yr

Deallus is a pharma services company, headquartered in United Kingdom.

Entry

2015

Hold

9yr

Exit

2024

Est. EV

–

Investor

ARCHIMED

Key facts

HQUnited Kingdom

SectorPharma Services

Founded in 2004, Deallus is a global life sciences consulting firm to 25* of the world’s top 30* pharmaceutical, biotechnology and vaccines…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Exit details: type, year, MOIC (buyer on Pro)

Start free

Already a member? Sign in

More from MED I

Other portfolio companies in the same fund.

Esperion Therapeutics

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Apera Asset Management

Last updated April 2026 · Sourced from public filings